-
Kelly West lecturer outlines next steps for more precise definitions, preventions, and treatments for type 2 diabetes
Mohammed K. Ali, MD, MSc, MBA, who was being honored for his contributions to diabetes epidemiology, said the field is poised to move beyond a “one-size-fits-all” approach to diabetes public health policies.
-
Glucagon/GLP-1 receptor dual agonist demonstrates efficacy for obesity and MASLD
Matthias H. Tschöp, MD, and other researchers detailed phase 3 results of SYNCHRONIZE-1 and SYNCHRONIZE-MASLD showing that survodutide leads to significant weight loss, reduction in liver fat, and other health improvements.
More 2026 Scientific Sessions News
Scientific Sessions Newsmakers
-
Innovation Challenge elevates creative solutions to diabetes challenges
Leaders of three start-up ventures pitched their novel product ideas at the Scientific Sessions and exited with connections for opportunities to accelerate their visions for redefining diabetes care and treatment.
-
President of Medicine & Science calls for unifying biomedical science and social determinants of care
A. Enrique Caballero, MD, highlighted the progress advancing diabetes treatment and management while shedding light on existing gaps in care and advocating for integrating advances in science into the real-world context in which people live.
-
Banting Medalist encourages embracing the unexpected to drive medical innovation
In his award lecture, Takashi Kadowaki, MD, PhD, explained how contradictions between hypotheses and results have enabled him to achieve major breakthroughs in understanding type 2 diabetes.
-
Discussion to consider pragmatic solutions through diabetes technology across diverse demographics and settings
Michelle Litchman, PhD, APRN, FNP-BC, and other experts will examine data, challenges, and best practices around the use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) devices among children, older adults, the Deaf community, and inpatient populations.
-
Joint ADA/IDF symposium to address malnutrition-related diabetes diagnosis, treatment, and research needs
Peter E. H. Schwarz, MD, PhD, MBA, and other leading experts from across the globe will discuss the latest information on the prevention, diagnosis, and treatment of what an international working group has designated as type 5 or malnutrition-related diabetes.
-
Panel to offer strategies for supporting psychological wellbeing for women and girls with diabetes
Paige Trojanowski, PhD, and other panelists will present the latest findings on unique diabetes challenges during female adolescence, pregnancy, postpartum, parenting, menopause, and hormone replacement therapy.
Presenter Profiles
